Samjin Pharm (005500) — Cash Flow Reinvestment Rate
Samjin Pharm (005500) has a Cash Flow Reinvestment Rate of 0.93x as of June 2025, reinvesting ₩9.90 Billion (capex ₩3.78 Billion plus investments ₩-6.12 Billion) from operating cash flow of ₩10.63 Billion. See 005500 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samjin Pharm Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Samjin Pharm across 12 annual periods. For the full cash flow conversion analysis, see Samjin Pharm (005500) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Samjin Pharm (2013–2024)
Year-by-year capital reinvestment analysis for Samjin Pharm. See Samjin Pharm (005500) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | ₩19.21 Billion | ₩38.15 Billion | ₩18.34 Billion | ▼ -89.2% |
| 2023 | 4.68x | ₩38.97 Billion | ₩8.33 Billion | ₩20.72 Billion | ▼ -23.4% |
| 2022 | 6.10x | ₩105.56 Billion | ₩17.29 Billion | ₩35.50 Billion | ▲ +0.1% |
| 2021 | 6.10x | ₩146.16 Billion | ₩23.97 Billion | ₩74.60 Billion | ▲ +131.8% |
| 2020 | 2.63x | ₩62.78 Billion | ₩23.86 Billion | ₩30.60 Billion | ▲ +160.9% |
| 2019 | 1.01x | ₩23.83 Billion | ₩23.63 Billion | ₩12.04 Billion | ▲ +104.0% |
| 2018 | 0.49x | ₩14.87 Billion | ₩30.08 Billion | ₩8.24 Billion | ▲ +102.7% |
| 2017 | 0.24x | ₩9.09 Billion | ₩37.28 Billion | ₩8.86 Billion | ▲ +13.7% |
| 2016 | 0.21x | ₩10.43 Billion | ₩48.66 Billion | ₩7.80 Billion | ▼ -55.7% |
| 2015 | 0.48x | ₩9.16 Billion | ₩18.94 Billion | ₩7.66 Billion | ▲ +6.4% |
| 2014 | 0.45x | ₩14.74 Billion | ₩32.41 Billion | ₩13.35 Billion | ▼ -61.5% |
| 2013 | 1.18x | ₩8.70 Billion | ₩7.37 Billion | ₩6.83 Billion | — |